The California STEM Reporter
SEE OTHER BRANDS

Catch up with science and technology news from California

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on June 25, 2025

Synchronoss, 유럽-미국 데이터 프라이버시 프레임워크 인증 획득

Synchronoss, 유럽-미국 데이터 프라이버시 프레임워크 인증 획득

뉴저지주 브리지워터, June 26, 2025 (GLOBE NEWSWIRE) -- 통신사를 위한 개인 클라우드 플랫폼 분야를 선도하는 글로벌 혁신 기업 Synchronoss Technologies, Inc.(‘Synchronoss’)(나스닥: SNCR)가 미국 상무부 소관의 유럽-미국 데이터 프라이버시 프레임워크(DPF) 인증을 획득했다고 발표했다. DPF는 미국에서 활동하는 기관이 일반정보보호규정(GDPR) 등 유럽 개인정보 보호법을 준수하면서 …

Synchronoss Meraih Pensijilan Rangka Kerja Privasi Data EU-AS

Synchronoss Meraih Pensijilan Rangka Kerja Privasi Data EU-AS

BRIDGEWATER, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), peneraju dan inovator global dalam platform awan peribadi untuk sektor telekomunikasi, hari ini mengumumkan bahawa syarikat itu telah …

Synchronoss ได้รับการรับรองกรอบการปกป้องข้อมูลระหว่างสหภาพยุโรปและสหรัฐอเมริกา

Synchronoss ได้รับการรับรองกรอบการปกป้องข้อมูลระหว่างสหภาพยุโรปและสหรัฐอเมริกา

บริดจ์วอเตอร์ รัฐนิวเจอร์ซีย์, June 26, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. ("Synchronoss") (NASDAQ: SNCR) ผู้นำระดับโลกและผู้ริเริ่มในแพลตฟอร์มคลาวด์ส่วนบุคคลสำหรับธุรกิจโทรคมนาคม ประกาศในวันนี้ว่า บริษัทฯ …

Synchronoss 获欧盟-美国数据隐私框架认证

Synchronoss 获欧盟-美国数据隐私框架认证

布里奇沃特,新泽西州, June 26, 2025 (GLOBE NEWSWIRE) -- 电信行业个人云平台领域的全球领导者和创新者 Synchronoss Technologies, Inc. (以下简称 “Synchronoss”,NASDAQ: SNCR)今日宣布已获得由美国商务部管理的欧盟-美国数据隐私框架 (DPF) 认证。 DPF 是一种跨大西洋数据传输机制,可使总部位于美国的组织按照《通用数据保护条例》(GDPR) 等欧洲隐私法律接收和处理来自欧盟的个人数据。 …

Synchronoss 取得歐盟-美國資料私隱框架認證

Synchronoss 取得歐盟-美國資料私隱框架認證

布里奇沃特,新澤西州, June 26, 2025 (GLOBE NEWSWIRE) -- 領先在前的全球電訊業個人雲端平台創新公司 Synchronoss Technologies, Inc.(「Synchronoss」)(NASDAQ: SNCR)今天宣布已取得由美國商務部(U.S. Department of Commerce)管理的歐盟—美國資料私隱框架(Data Privacy Framework,DPF)認證。 DPF …

Acceleware Announces RF XL 2.0

Acceleware Announces RF XL 2.0

CALGARY, Alberta, June 25, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, will host an investor webcast on …

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …

ABeam Consulting (USA) Ltd. and Millennium EBS Establish Strategic Collaborations to Expedite ISO 20022 Implementation

ABeam Consulting (USA) Ltd. and Millennium EBS Establish Strategic Collaborations to Expedite ISO 20022 Implementation

LOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- ABeam Consulting (USA) Ltd. (“ABeam US”) and Millennium EBS, a BlueOne Card Inc. subsidiary, have announced a strategic collaboration under a newly signed Master Services Agreement (MSA) to jointly promote the …

NicSRS Now Offering DigiCert VMC to Enhance Email Security and Brand Trust

NicSRS Now Offering DigiCert VMC to Enhance Email Security and Brand Trust

Show your brand logo in email inboxes instead of generic initials. LOS ANGELES, CA, UNITED STATES, June 25, 2025 /⁨EINPresswire.com⁩/ -- NicSRS, a leading provider of advanced digital certificates and online security solutions, is excited to share its new …

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its …

Clip Money Inc. Announces Results of Voting at Annual Meeting of Shareholders

Clip Money Inc. Announces Results of Voting at Annual Meeting of Shareholders

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce the results of voting at its …

Vor Bio Announces $175 Million Private Placement

Vor Bio Announces $175 Million Private Placement

CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …

Data Squared (Data²) Secures Patent for Hallucination-Resistant, Explainable AI Systems

Data Squared (Data²) Secures Patent for Hallucination-Resistant, Explainable AI Systems

BELLEVUE, Wash., June 25, 2025 (GLOBE NEWSWIRE) -- Data Squared (Data²), a Service-Disabled Veteran-Owned Small Business dedicated to helping public and private sector organizations unlock the full potential of their data, today announced that the U.S. …

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …

Main Results of 2025 Annual and Extraordinary General Meeting

Main Results of 2025 Annual and Extraordinary General Meeting

REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, …

BIGtoken Welcomes Pro Soccer and Sports Industry Leaders Aly Wagner and Adam Eyre as Strategic Investors and Advisors

BIGtoken Welcomes Pro Soccer and Sports Industry Leaders Aly Wagner and Adam Eyre as Strategic Investors and Advisors

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- BIGtoken, the Web3 marketing platform helping organizations turn real-world audiences into owned, monetizable data, today announced a strategic partnership with soccer industry veterans Aly Wagner and Adam Eyre. …

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.

Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions